SciSparc's Drug Discovery Joint Venture MitoCareX Bio Successfully Developed its Core Algorithm to allow suitable Modelling of Human Mitochondrial Carriers for Accelerating its Cancer Drug Discovery Program

TEL AVIV, Israel, May 08, 2023 -- SciSparc Ltd. , a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system,... | May 8, 2023

Related Keywords

Israel , ,Exchange Commission ,Scisparc Ltd ,Company Or Scisparc ,Nasdaq ,Carex Bio ,Mitocarex Bio ,Tourette Syndrome ,Looking Statements ,Private Securities Litigation Reform Act ,Annual Report ,Scisparc Stock Exchange ,News ,Information ,Press Release ,El ,Bay ,023 ,Scisparc ,Specialty ,Harmaceutical ,Company ,Ocusing ,N ,The ,Development ,F ,Therapies ,O ,Treat ,Disorders ,Central ,Ervous Sprc Il0010951403 ,